
Australia’s competition regulator, the Australian Competition and Consumer Commission (ACCC), has intensified its legal action against Qantas Airways, announcing plans to seek a hefty fine of “hundreds of millions” of dollars. This move comes a day after the ACCC initiated legal proceedings against the carrier, accusing it of selling tickets to over 8,000 flights despite their cancellation.
In court filings on Thursday, the ACCC alleged that between May and July 2022 Qantas violated consumer law by failing to disclose the cancellation status of thousands of flights. Qantas, in response, stated it would carefully review the allegations and provide a formal response in court. The airline emphasized that the period in question coincided with unprecedented challenges faced by the entire airline industry due to the global pandemic.
Read more: The ACCC’s Ongoing Digital Platforms Services Inquiry: Regulatory Reform
The ACCC’s Chair, Gina Cass-Gottlieb, reiterated the severity of the alleged misconduct, emphasizing that the proposed penalty is not merely a cost of doing business but aims to deter similar conduct in the future. Under Australian consumer laws, Qantas could face a maximum penalty of up to 10% of its annual turnover, which stood at A$19.8 billion in the fiscal year ending June.
Qantas shares experienced a notable decline, dropping nearly 2% to A$5.83 in afternoon trading on Friday. This followed a previous day’s dip of 3.81%, marking the lowest share price since November 22.
Cass-Gottlieb highlighted the intention to surpass the previous record penalty imposed on automaker Volkswagen in 2019, which amounted to A$125 million ($81 million) for breaching Australian consumer laws.
Source: CA Movies Yahoo
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas